Valutazione Metabolica Della Nefrolitiasi Recidivante

Marangella M. Metabolic evaluation of calcium nephrolithiasis. J Nephrol 1995; 8: 179–84.

Chaussy C. , Brendel W. , Schmiedt E. Extracorporeally induced destruction of kidney stones by shock waves. Lancet 1980; 2: 1265–7.

Resnick M.I. , Pak C.Y.C. Is the metabolicwork-up of urolithiasis necessary? J Urol 1987; 137: 960–1.

Marangella M. , Vitale C. , Petrarulo M. Valutazione metabolica della nefrolitiasi calcica. Giorn Tecniche Nefrol Dial 1996; 8: 23–33.

Coe F.L. , Favus M.J. , Pak C.Y.C. , Parks J.H. , Preminger G.M. Kidney stones. Medical and surgical management. Lippincott-Raven publishers, Philadelphia, NW; 1996.

Jagger P. Renal stone disease in the 1990s: the powder keg and tinderbox theory. Current Opinion Nephrol Hypertens 1992; 1: 141–8.

Pak C.Y.C. , Britton F. , Peterson R. Ambulatory evaluation of nephrolithiasis: classification, clinical presentation and diagnostic criteria. Am J Med 1980; 69: 19–30.

Pak C.Y.C. , Peters P. , Hurt G. Is selective therapy of recurrent nephrolithiasis possible? Am J Med 1981; 71: 615–22.

Lingeman J.E. , Preminger G.M. , Wilson D.M. Kidney stones: identifying the causes. Patient Care 1990; 24: 31–43.

Minetti L. , Colusso G. , Surian M. Nefrolitiasi calcica. In: Minetti L. , Colusso G. , Surian M. (Eds). Nefrolitiasi: fisiopatologia e clinica. Acta Medica Edizioni e Congressi, Roma 1985; IV: 31–78.

Minetti L. , Colusso G. , Surian M. Aspetti fisicochimici della formazione dei calcoli renali. In: Minetti L. , Colusso G. , Surian M. (Eds). Nefrolitiasi: fisiopatologia e clinica. Acta Medica Edizioni e Congressi, Roma 1985; II: 9–17.

Pak C.Y.C. Physiological basis for absorbitive and renal hypercalciurias. Am J Med 1979; 237: 415F–23F.

Brannan P.G. , Morawski S. , Pak C.Y.C. Selective jejunal hyperabsorption of calcium in absorptive hypercalciuria. Am J Med 1979; 66: 425–8.

Pak C.Y.C. , Mc Guire J. , Peterson R. Familial absorptive hypercalciuria in a large kindred. J Urol 1981; 126: 717–9.

Shen F.H. , Baylink D.J. , Nielson R.L. Increased serum 1,25-dihydroxyvitamin D in idiopathic hypercalciuria. J Lab Clin Med 1977; 90: 955–62.

Borghi L. , Meschi T. , Novarini A. Paziente con nefrolitiasi. Profilo diagnostico di rischio litogeno e follow-up ambulatoriale. Fed Med 1993; 14: 27–34.

Henneman P.H. , Benedict P.H. , Forbes A.P. Idiopathic hypercalciuria. N Engl J Med 1958; 259: 801–7.

Zerwekh J.E. , Holt K. , Pak C.Y.C. Natural urinary macromolecolar inhibitors: attenuation of inhibitory activity by urate salts. Kidney Int 1983; 23: 838–41.

Smith L.H. Hyperoxaluric states. In: Coe F.L. , Favus M.J. (Eds). Disorders of bone and mineral Metabolism. Raven Press, New York 1992: 707–27.

Dobbins J.W. , Binder H.J. Effects of bile salts and fatty acids on the colonic absorption of oxalate. Gastroenterology 1976; 70: 1096–100.

Stauffer Q.J. Hyperoxaluria and intestinal disease: the role of steatorrhea and dietary calcium in regulating intestinal oxalate absorption. Digest Dis 1977; 22: 921–8.

Curhan G.C. , Willett W.C. , Rimm E.B. , Stampfer M.J. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med 1993; 328: 833–8.

Christiansen C. Consensus developments conference: diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med 1993; 94: 646–50.

Marangella M. , Cosseddu D. , Vitale C. Studio dei parametri di riassorbimento osseo nelle sindromi ipercalciuriche. Pandora 1994; 6: 29–32.

Nicar M.J. , Skurla C. , Sakhaee K. Low urinary citrate excretion in nephrolithiasis. Urology 1983; 21: 8–14.

Pak C.Y.C. Citrate and renal calculi: new insights and future directions. Am J Kidney Dis 1991; 17: 420–5.

Nicar M.J. , Hill K. , Pak C.Y.C. Inhibition by citrate of spontaneous precipitation of calcium oxalate, in vitro. J Bone Mineral Res 1987; 2: 215–20.

Baruch S.B. , Barich R.L. , Eun C.K. Renal metabolism of citrate. Med Clin North Am 1975; 59: 569–82.

Simpson D.P. Regulation of renal citrate metabolism by bicarbonate ion and pH: observations in tissue slices and mitochondria. J Clin Invest 1967; 16: 225–38.

Levy F.D. , Pak C.Y.C. Ambulatory evaluation of Nephrolithiasis: an update of a 1980 protocol. Am J Med 1995; 98: 50–9.

Pak C.Y.C. , Sakhaee K. , Fuller C. Successfull management of uric acid nephrolithiasis with potassium citrate. Kidney Int 1986; 30: 422–8.

Yu T.F. , Gutman A.B. Uric acid nephrolithiasis in gout. Pre-disposing factors. Ann Intern Med 1967; 67: 1133–48.

Hennerman P.H. , Wallach S. , Dempsey E.F. Metabolic defect responsible for uric acid stone formation. J Clin Invest 1962; 41: 537–42.

Gutman A.B. , Yu T.F. A three-component system for regulation of renal excretion of uric acid in man. Trans Assoc Am Physicians 1961; 74: 353–65.

Halperin E.C. , Thier S.O. Cystinuria. In: Coe F.L. , Brenner B.M. , Stein J.H. (Eds). Nephrolithiasis. Churchill Livingstone, New York 1980; 5(10): 209–30.

Broadus A. , Thier S.O. Metabolic basis of renal stone disease. N Engl Med 1979; 300: 839–45.

Linari F. , Marangella M. , Fruttero B. , Bruno M. The natural history of cystinuria: a 15 year follow-up in 106 patients. In: Smith L. , Robertson W. , Finlayson B. (Eds). Urolithiasis, clinical and basic research. Plenum Press, New York 1981: 145–54.

Griffith D.P. Struvite stones. Kidney Int 1978; 13: 372–82.